Author

S. Dreyer

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Evolutionary Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Research Focus:drug response / drug discovery· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Assay:DNA methylation· 1

Frequent Co-Authors

A. A. Sylverken· 1 shared A. Ashworth· 1 shared A. Biankin· 1 shared A. Gulati· 1 shared A. Johns· 1 shared Australian Pancreatic Genome Initiative· 1 shared B. Nelson· 1 shared B. Serrels· 1 shared

Activity by Year

2018-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 16 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. A. Sylverken

Author profile →

4 papers

Recent·Most cited

Carbapenem- and cefiderocol-resistant Enterobacterales in surface waters in Kumasi, Ashanti Region, Ghana

E. Eger, T. Homeier-Bachmann, E. Adade, S. Dreyer, S. E. Heiden, P. O. Tawiah, A. A. Sylverken, S. Knauf, K. Schaufler

The study found carbapenem-resistant Enterobacterales in surface waters in Ghana, with some isolates also showing resistance to cefiderocol.

bioRxiv · Aug 4, 2023 · PreprintMicrobiology

Unraveling the relationship between cancer and life history traits in vertebrates

S. Bulls, L. Platner, W. Ayub, N. Moreno, J.-P. Arditi, S. Dreyer, S. McCain, P. Wagner, S. Burgstaller, L. R. Davis, L. G. R. Bruins - van Sonsbeek, D. Fischer, V. J. Lynch, J. Claude, S. Glaberman, Y. Chiari

The paper analyzes cancer prevalence across vertebrates to explore its relationship with life history traits, finding low rates in turtles and high rates in squamates and mammals.

bioRxiv · Jul 12, 2022 · PreprintEvolutionary Biology

Targeting DNA damage response and Replication Stress in Pancreatic Cancer

S. Dreyer, R. Upstill-Goddard, V. Paulus-Hock, C. Paris, E. Maria-Lampraki, E. Dray, B. Serrels, S. Rebus, H. Brunton, C. Nourse, U.-M. Bailey, M. Jones, K. Moran-Jones, D. Wright, F. Duthie, , Lord

The paper identifies novel therapeutic strategies for pancreatic cancer by analyzing DNA damage response and replication stress in patient-derived cell lines.

bioRxiv · Jul 24, 2019Cancer Biology

Macrophage Released Pyrimidines Inhibit Gemcitabine Therapy in Pancreatic Cancer

C. J. Halbrook, C. Pontious, H.-J. Lee, I. Kovalenko, Y. Zhang, L. Lapienyte, S. Dreyer, D. M. Kremer, P. Sajjakulnukit, L. Zhang, B. Nelson, H. Hong, S. Kemp, D. Chang, A. Biankin, , C. A. Lyssiotis

This study shows macrophages in pancreatic cancer release pyrimidines that inhibit gemcitabine therapy by competing with the drug for uptake and metabolism, and reducing macrophage burden improves treatment response.

bioRxiv · Nov 5, 2018Cancer Biology